BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Intestine
,
Neocentromeres
,
Tamoxifen
,
rs2300478
,
SNCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
win 59075
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cyto…
Molecular mechanisms of tirapazamine (SR 4233, Win 59075)-induced hepatocyte toxicity under low oxyg…
Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-…
DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.
Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarco…
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Canc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ